导管消融治疗房颤试验（Catheter Ablation for the Cure of Atrial Fibrillation Trial, CACAF）是第一个多中心、前瞻性、随机、对照研究。
基于1个网页-相关网页
导管消融治疗房颤试验
Catheter ablation for atrial fibrillation trial
以上为机器翻译结果，长、整句建议使用 人工翻译 。
试验连续性纳入232例适于左房经导管射频消融治疗的阵发性或持续性房颤患者。
A total of 232 consecutive patients with paroxysmal or persistent atrial fibrillation who were candidates for radiofrequency left atrial catheter ablation were included in the study.
youdao
应用推荐
模块上移
模块下移
不移动